ASTELLAS PHARMA, INC. (ALPMF)
Clinical trial NCT03971253 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-05-31 → 2026-05-29 3. primary completion date: 2026-05-31 → 2026-05-29 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT03971253 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-05-31 → 2026-05-29 3. primary completion date: 2026-05-31 → 2026-05-29 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical